Wednesday saw Inovio Pharmaceuticals (NASDAQ: INO) stock slide -6.84% with its share price continuing on that downward slope again today. It is currently trading at $10.29 premarket on Thursday after closing Wednesday’s session at $10.63 per share…
Source: TradingView
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
But what has caused the drop…
Well, it comes down to Muddy Waters Research, a privately held investment fund and due diligence company, who stated that they are short the company.
The research company stated that the reasons for its short position are a recent court decision and the surge in its price after the hype about its COVID-19 vaccine.
Muddy Waters stated in a Tweet that “a recent court decision against INO makes it clear that INO lacks manufacturing capacity to get remotely near purported goal of 1 mm doses in ‘20 & 100 mm in ’21.”
The court decision refers to a recent case where Inovio sued its primary supplier, VGXI, for a temporary injunction to force the transfer of manufacturing technology, with Muddy Waters stating that without the transfer Inovio doesn’t have the capacity…
Inovio is now waiting for the final judgement on the case.
Muddy Waters went on to state that they don’t see Inovio competing with the five Operation Warp Speed vaccine candidates.
And, in the final Tweet of the thread, the investment fund said they “concur” with a recent report by Citron Research on Inivio that called Inovio “one of the longest running and most blatant stock promotion schemes ever witnessed by Citron.”
Ouch!
PEOPLE WHO READ THIS ALSO READ:
